NIH-funded study identifies gene variant as potential drug target
Defying the odds, an individual at high risk for early-onset Alzheimer’s disease remained dementia-free for many years beyond what was anticipated. A study funded in part by the National Institute on Aging (NIA), part of the National Institutes of Health, led researchers to suggest that a gene variant may be the key, perhaps providing a new direction toward developing a treatment.
The research focused on the case of a woman who carried a gene mutation known to cause early-onset Alzheimer’s. However, she did not develop signs of the disease until her seventies, nearly three decades after her expected age of onset. The researchers suspect that she may have been protected because in addition to the gene mutation causing early-onset Alzheimer’s in her family, she also had two copies of the APOE3 Christchurch (APOE3ch) gene variant. Findings of this case study as published in Nature Medicine suggest that two copies of the APOE3ch variant, named after Christchurch, New Zealand where it was first identified, may protect against Alzheimer’s.
“Sometimes close analysis of a single case can lead to discovery that could have broad implications for the field,” said NIA Director Richard J. Hodes, M.D. “We are encouraged that as part of our wide array of studies, this research in the unique genetic makeup of an exceptional individual can reveal helpful information.”
Early-onset Alzheimer’s disease is rare, representing less than 10% of all people who have Alzheimer’s. It typically occurs between a person’s 30s to mid-60s. Risk for both early- and late-onset Alzheimer’s disease is affected by genetic factors.
For the study, researchers led by investigators at Massachusetts General Hospital, Boston, in collaboration with the University of Antioquia, Medellin, Colombia, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, and Banner Alzheimer’s Institute, Phoenix, looked at genetic data from a Colombian family with more than 6,000 living members. Family members who carry a rare gene mutation called Presenilin 1 (PSEN1) E280A, have a 99.9% risk of developing early-onset Alzheimer’s disease.
The researchers confirmed that the woman in this case carried the PSEN1 E280A mutation, which caused early-onset Alzheimer’s in her other family members. However, she also had two copies of the APOE3ch gene variant, while no other affected family member carried two copies of this variant. Affected family members develop Alzheimer’s in their 40s, but she remained disease free until her 70s. Imaging tests showed that the woman had only minor neurodegeneration. She did have large amounts of amyloid protein deposits, a hallmark of Alzheimer’s disease, in her brain. But the amount of tau tangles, another hallmark of the disease, and the one more correlated with how thinking and memory are affected, was relatively low.
Experiments as part of the study showed that the APOE3ch variant may reduce the ability of APOE to bind to certain sugars called heparan sulphate proteoglycans (HSPG). APOE binding to HSPG has been implicated as one mechanism that may contribute to the amyloid and tau protein deposits that destroy the brain. The research suggests that a drug or gene therapy that could reduce APOE and HSPG binding has the potential to be a new way to treat or prevent Alzheimer’s disease.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Alzheimer's caretaker helps open new adult daycare facility in Georgetownon November 30, 2019 at 1:23 am
GEORGETOWN, Texas — Vic Figurelli's wife, Camille, died in 2016. She was diagnosed with Alzheimer's in 2011. Between those years, Vic had to make tough decisions to take care of Camille, including ...
- Woman finds purpose, passion in aiding Alzheimer’s caregiverson November 30, 2019 at 1:06 am
DALLAS — Maryan Daily was frantic when she started her caregiver support group about 15½ years ago. Daily’s husband, John, was diagnosed with Alzheimer’s in 1996 and, until his death in 2004, she had ...
- The 10 states with the highest rates of Alzheimer’s diseaseon November 29, 2019 at 11:30 am
Alzheimer’s disease is the sixth leading cause of death in the United States, with death rates on the rise.
- Her husband died of Alzheimer's. Now she's giving back to otherson November 29, 2019 at 4:04 am
Her husband died from Alzheimer's disease in 1999. Since then, this woman has been on a mission to give back to others. She chooses to honor her late husband with a ...
- Calorie restriction slows age-related microbiota changes in an Alzheimer’s disease model in female miceon November 29, 2019 at 3:15 am
Alzheimer’s disease (AD) affects an estimated 5.8 million Americans, and advanced age is the greatest risk factor. AD patients have altered intestinal microbiota. Accordingly, depleting intestinal ...
- Lying helped my family live with Alzheimer'son November 29, 2019 at 1:00 am
“We got $5 million for the house, Dad,” I said to my father. I was lying. However, as the angst washed from his face, I knew that this untruth — what Alzheimer’s experts call a compassionate lie — was ...
- Successful Aging: What you need to know about Alzheimer’s diseaseon November 28, 2019 at 12:08 pm
November was Alzheimer’s Awareness month, which was designated by President Reagan in 1983. Given the importance of the topic, here are some distilled facts (or myths) in the form of a true-false quiz ...
- Will a Treatment for Alzheimer’s Ever Be Found?on November 28, 2019 at 9:24 am
One way to find what’s broken is through genetics, but the first wave of genetic studies in the 80s and 90s only had the technical capabilities to investigate Alzheimer’s cases that run in families, ...
- Alzheimer’s Disease Cure Might Be In Sighton November 27, 2019 at 11:19 pm
A key insight uncovered by researchers from Harvard might lead to the development of drugs that can finally cure Alzheimer's disease. One surprising reason people experience migraine is eating bread ...
- Lawyers say federal death row prisoner has Alzheimer'son November 27, 2019 at 9:55 am
WASHINGTON — Lawyers for a federal death row inmate convicted of rape and murder have asked a federal judge to halt his scheduled execution next month because the prisoner has Alzheimer's disease and ...
via Bing News